Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0000905148-25-003069

Chief Accounting Officer sold 1,809 shares at an average $11.61 ($21,009)

From the SEC's structured data for this filing

Trades in this filing

Grant-Huerta Yanina · Chief Accounting Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2025-08-18 Sale : show line 1 in the form −55 $11.61 $638 37,012 D
2025-08-18 Sale : show line 2 in the form −86 $11.61 $999 36,926 D
2025-08-18 Sale : show line 3 in the form −1,668 $11.61 $19,372 35,258 D
Open-market sales · 1,809 sh · avg $11.61 · $21,009
Loading xslF345X05/form4.xml…